Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > 60% of the road = 270-days
View:
Post by ScienceFirst on Jul 12, 2022 1:15pm

60% of the road = 270-days

270-day data is 60% of 450-day data.  


August 31, we will have 270-day data on 11 more patients.  That will make our durable target statistically more and more significant.

Comment by fredgoodwinson on Jul 12, 2022 1:33pm
Yes agree August 31st - the 50 day-away dateline mentioned in my last post when the evidence should at last leave little room for doubt.
Comment by Eoganacht on Jul 12, 2022 1:42pm
From CancerSlayer's post: A look at the performance of these new kids on the block:  12 month CR data for BCG unresponsive CIS.... Nadofaragene Firadenovec = 24% N-803 + BCG = 40% CG0070 (as a single-agent therapeutic) = 27.5% How will TLD1433 stack up?
Comment by Camphikefish on Jul 12, 2022 2:16pm
Looks like we need to come in at 25-30 % at a minimum with our 12 month CR data. Thoughts on our chances/probability?
Comment by LaserStock29 on Jul 12, 2022 9:08pm
3/10 was known wayback 1993 photofrin 60% w damages to organ 2022 we better minimum be over 60%
Comment by Rumpl3StiltSkin on Jul 13, 2022 8:48am
I believe since NMIBC, via instilations, is so in-exact. We might be doing pretty well with %s in the 40s or 50s. Maybe we get as high as the 60s after AA and the much higher numbers of patients. Solid tumor indications is I think where TLT could see very high percentages.  Of course the best thing about TLTs ACT is how safe and repeatable it is. Turning NRs to PRs to CRs. Sure, I wish some ...more  
Comment by Oilminerdeluxe on Jul 13, 2022 10:17am
You guys with spreadsheets. How many patients have reported 270 and 360 days by now? And, if possible, are you able to tell how many of these have had the optmized treatment? If I am not mistaken there should be a bunch of optimized people in the next update at these points, whenever it comes. It could hopefully change the CR quite a bit.
Comment by ScienceFirst on Jul 13, 2022 11:13am
Optimized patients: Post August 1, 2020
Comment by ScienceFirst on Jul 13, 2022 11:39am
May 29, 2020 MD&A makes mention of 12 Ph. 2 patients treated August 28, 2020 MD&A makes mention of 12 Ph. 2 patients treated September 30, 2020 MD&A makes mention of 12 Ph. 2 patients treated April 28, 2021 MD&A makes mention of 18 Ph. 2 patients treated May 30, 2021 MD&A makes mention of 19 Ph. 2 patients treated August 30, 2021 MD&A makes ...more  
Comment by Oilminerdeluxe on Jul 13, 2022 11:43am
Thank you!
Comment by LaserStock29 on Jul 14, 2022 9:24am
Why not just do the pp now. The world is just getting tougher now to live. Same terms as 2019 for canadians 1 + 1 warrant free trading. . We've already treated 41. 11 still eed 2nd treatment. Eoy is no.25 at 450 Our trial is over. The only way we should be treating is the next phase in usa with BTD and AA for the latter 80 patients. At a $2 pps
Comment by ScienceFirst on Jul 14, 2022 9:34am
Strange thinking LS29. You were whining about a potential pp weeks ago while TLT management were clear about no po and while Roger and Kristina had invested 750K$ of their own money and now, you want a po @0.28$ before August 31 new set of data!!! TLT management know what they're doing and where they're heading.  And they have more insights than you.  Clinical data will dictate ...more  
Comment by ScienceFirst on Jul 14, 2022 9:37am
Last week, Merck was able to pay 40G$ for SEAGEN, even though financing conditions are getting more challenging.  Big pharmas have enough liquidity if they know what we can bring them in terms of future revenues.
Comment by IFlyTheUnicorn on Jul 14, 2022 10:07am
This post has been removed in accordance with Community Policy
Comment by skys1 on Jul 14, 2022 11:16am
Agree ScienceFirst, that sure was a strange statement by LS29.
Comment by Rumpl3StiltSkin on Jul 14, 2022 12:57pm
I'm certain that TLT wants to avoid another disastrous pp down at these levels, IF they can. Indeed, SP seems to have some of that already priced in. They did say at this recent AGM that they would need $$$ within 6th months. Based on not getting the SP up higher, raising their profile, jetting a jv or buyout, etc. This is probably the last bet I'll be making on TLT, that they will ...more  
Comment by Eoganacht on Jul 14, 2022 2:48pm
In his recent talk with Dr. Roupret, Dr Kamat said of the N803 plus BCG combined treatment, that the 12 month 40% CR results, "seem almost too good to be true with very low toxicity" And "clearly that is something that we're all excited about that has been filed with the fda and we're waiting to see if it gets approved." More and more data from our phase 2 will be ...more  
Comment by CancerSlayer on Jul 14, 2022 6:40pm
  Nice post Eoganacht... I always have to keep my eye on the forest for the trees when discussing TLT's transcending/versatile ACT & its value.  You could probably count on one hand the number of drugs/treatments under study (globally) that have the realistic potential to "effectively" & "safely" treat both a variety of infectious diseases as well as ...more  
Comment by Yajne on Jul 14, 2022 9:03pm
Great post CS. Your last line re: aerosols is thought provoking..yes it does seem that bigPharma are overlooking the fact that our airways are our line of first defense!! Cancerslayer wrote: Nice post Eoganacht... I always have to keep my eye on the forest for the trees when discussing TLT's transcending/versatile ACT & its value.  You could probably count on one hand the number ...more  
Comment by CancerSlayer on Jul 14, 2022 10:49pm
Hi Yajne...thanks.  All the currently approved commercial vaccines are systemically administered & completely bypass the airway.  The potential advantage of using an intranasal vaccine is that it can induce both airway/mucosal & systemic immunity (both antibody-mediated & cell-mediated).  It also has the additional advantage of ease of administration...no shot required ...more  
Comment by Yajne on Jul 14, 2022 11:49pm
Makes total sense CS! ...unless you are Pharma and deeply invested into 'the shot'. Aerosol is a new paradym in the C19 space...so many people with their blinders on. Hope you've shared your aerosol ideas with Dr Mandel at TLT.
Comment by ibaru55 on Jul 15, 2022 1:33am
This post has been removed in accordance with Community Policy
Comment by Infinity on Jul 15, 2022 9:42am
Cancer Slayer, I am intrigued by your observation on nasal aerosol type treatment approach. This approach could very well be the break through in any virus (Corona, Zika or Sars..type) vaccine. It could raise the efficacy, potency and may be even the durability?. Many including myself are getting tired of simply repeating the vaccine based on scant information and data. Yajne, Thanks for ...more  
Comment by Rumpl3StiltSkin on Jul 15, 2022 9:56am
Although I agree that this MoD is exciting, would work better/easier than shots, etc. I think TLT is already solidly on the AvantGarde track with their PDT cancer ACT. I say let them go the more traditional route with this, work with Canada Govt. Then down the line maybe explore this as a MoD for Viraii and Bacterium and certain cancer indications.
Comment by ScienceFirst on Jul 15, 2022 10:15am
If nasal aerosol deliver more efficiency than shots, it would have been a long time ago that aerosol would have been brought to the forefront as it would have given a hedge to the pharma or biotech that would have  brought it. Pharmas already have aerosol for some indications but it is based on facts and science.  So if COVID-19 shots would have been the best efficient methods, it ...more  
Comment by 99942Apophis on Jul 15, 2022 11:11am
ScienceFirst wrote If nasal aerosol deliver more efficiency than shots, it would have been a long time ago that aerosol would have been brought to the forefront as it would have given a hedge to the pharma or biotech that would have  brought it. Pharmas already have aerosol for some indications but it is based on facts and science.  So if COVID-19 shots would have been the best ...more  
Comment by Yajne on Jul 15, 2022 11:34pm
I've had SF (aka Bencro) in my ignore pile so missed this. Did he really say that? For a guy I once considered a Brainiac, I probably need to reconsider after a wild-a$$ assumption like that about pharma. Maybe they were always on the highly profitable needle/shot delivery route, with no regard for aerosol. Apparently SF is not the brainiac he considers himself, but rather a sheep blindlly ...more  
Comment by O12009 on Jul 16, 2022 9:09am
So it must be time to pick a fight and drive the stock price down again. Will make for a good buying opportunity.  GLTA
Comment by ScienceFirst on Jul 16, 2022 5:12pm
Yajne ... You always say that: "I've had SF in my ignore pile so missed this." Like if we believed you. Still into plot theories? ____________   ScienceFirst(6589) User Actions   July 12, 2022 - 08:13 AM 144 Reads  Post# 34817355 RE:RE:RE:RE:RE:Theralase Is still Flying Under the Radar ...more  
Comment by langosta on Jul 16, 2022 7:50pm
Hands up everyone who can claim that they have never said anything that they have regretted.
Comment by Rumpl3StiltSkin on Jul 16, 2022 9:13pm
Hmm, things I shouldn't have said or things I regretted saying?? ;-)
Comment by skier59 on Jul 16, 2022 9:57pm
I think many of us are in that boat ! Shame you can't delete a stupid post you regret. However, just to express my thought, Roger deserves to get back into his CEO chair. I've seen much worst things fly by without a scratch to the CEO at other companies. Roger created TLT, it's his vision, let him finish it with Pride and Conviction. This is finally coming down to the final few ...more  
Comment by FGPstock on Jul 17, 2022 10:26am
Skier, we all do and say things that we regret. That is part of life and learning. But when you tell the world, your shareholders, potential investors, etc that you have FDA and Health Canada approval on something when you haven't even applied, that is willful fraud, in my opinion. It is pretty hard to get in trouble with the OSC. We all know roger is currently violating his settlement ...more  
Comment by Lesalpes29 on Jul 18, 2022 7:31am
Trouble maker from day 1. Be ready, we could see the price going down. A short position to cover. A real shame...
Comment by Infinity on Jul 18, 2022 10:42am
FGP,  I am having difficulty understanding your point.   Both Shaun Shirazi and Kipton Lade are previous employees of TLT.  Their contracts were terminated with or without mutual consent.   EX- Managers can say what ever they want against the management without violating any of the terms of their NDA etc.. However, I have not come across any damaging statements from ...more  
Comment by CAinPlap on Jul 18, 2022 12:35pm
Would Roger have to wait until next AGM to be appointed CEO?
Comment by livermore2 on Jul 18, 2022 12:42pm
Like Steve Jobs to Apple - would personally love to have Roger back!!!
Comment by ScienceFirst on Jul 15, 2022 7:26am
CancerSlayer ... Th National Microbiology Laboratory (NML) is the one that has the best expertise to propose the best delivery method to Theralase, as per one of Dr. Kobasa's comment.
Comment by Rumpl3StiltSkin on Jul 14, 2022 8:14pm
True Eoga, at that point does TLT even do a PP? At that point they could do a JV or even get bought out? Many more options....
Comment by CancerSlayer on Jul 14, 2022 10:12pm
I don't see an early JV or buyout happening if TLT is at all interested in maximizing value for themselves or their shareholders.  There's just so much additional potential/value post NMIBC approval.  Considering we can get to ~$1 US post approval (? on this exchange), it would be a low-risk play imo to dilute by ~15% in order to build cash/R&D/commercial reserves & ...more  
Comment by Rumpl3StiltSkin on Jul 14, 2022 10:20pm
Well Slayer,  It might not happen that early. A JV deal on just NMIBC might be a good deal for TLT. There are other partial deals like that that could bring them some money. They said they have 6 mos of $$ left, Yet I think that is worse case? Assuming they don't get any SP boost for some reasons.  All they need is a boost above .50c and Oct warrants should come into play. Lots of ...more  
Comment by Infinity on Jul 15, 2022 7:39am
Cancer Slayer,  Dilution to raise money would be an acceptable option.  However, prior to raising the money by PP or what ever means, I would like to see some positive news reports.  I believe, the management likes to keep things very quiet, even tend to under play positive news for reasons that is known only to them.  I for one can not wait till Roger gets back from the ...more  
Comment by ScienceFirst on Jul 15, 2022 7:59am
Infinity ... Good points. JV deal would probably not be signed before Roger is reinstated as a CEO, after Feb. 2023.  He deserves to be back in that role, no doubt, given where he brought us (on the verge of a Breakthrough designation and next SOC). JV would bring upfront payment, avoiding the need for a pp.  Our Ph. 2 NMIBC data is worth approx. 600M$+ now, as per industry's ...more  
Comment by FGPstock on Jul 15, 2022 12:11pm
Bencro, what are you smoking today? y would anyone wnat roger back in power. the company has progressed more since he has been gone than all of the years he was in control.He still gets paid more in salary and options than any other employee. He has admitted to lying about finanacials, patents, etc for 10+ years. I am not sure that is the guy I want negotiating a deal w big pharma.
Comment by skys1 on Jul 15, 2022 1:04pm
FGP, weather you, me, or the BODs like it or not, Roger was, is, and for at least the immediate future will be the CEO. That's why Shawn left, because 'Roger is making the decisions". The primarily why the Commission came down on him so hard was his being wildly loose with his guidance. However, he did make a major effort at PR with frequent interviews & PRs and such which is ...more  
Comment by FGPstock on Jul 15, 2022 1:20pm
skys1, if your statement is true that roger "is, was and in the immediate future" the CEO, which I believe is true and have spoken to shawn, Kipton Lade and the fomer IR team and they concurred Roger is running things in the background, the roger is clearly violating the terms of his settlement agreement. Why give the OSC more reason to pour water on a potential cancer cure, ego???
Comment by skys1 on Jul 15, 2022 1:46pm
OK FGP, I'll enumerate a bit more of Roger's strengths. Many years ago after Bob M's write up, I did my DD on TLT. I became convinved of 1433's remarkable potential so I was very concerned about the strength of it's patent protection. Back then you could pick up the phone and speak to Roger anytime you desired. We had extensive conversations on Roger's extensive patent work ...more  
Comment by Eoganacht on Jul 15, 2022 2:59pm
I agree. Roger made some mistakes but the OSC way overreacted. It would be great if he's the one to bring this across the finish line. It will be an amazing achievement.
Comment by FGPstock on Jul 15, 2022 3:57pm
Eog, I don't think you should tell the world something has FDA and Health Canada Approval when it doesn't, that is outright fraud... overstating the financials projections for 10+/- years isn't too honorable imo either. I think the OSC went easy as, like skys1 said, roger is still the ceo...
Comment by Longholder99 on Jul 17, 2022 6:03pm
I firmly believe our one and only CEO will.bring this home. ACT and C19. Once RDW is back in the left chair we will see whats what.
Comment by ScienceFirst on Jul 15, 2022 7:51pm
Look at our Bozo FGPSTOCK! The guy that thought bullet points missing in a corporate presentation was what made the stock drop at an opening! _____________ FGPstock - (7/15/2022 12:11:59 PM) RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:60% of the road = 270-days Bencro, what are you smoking today? y would anyone wnat roger back in power. the company has progressed more since ...more  
Comment by FGPstock on Jul 15, 2022 10:38pm
Ben, everything posted is 100% accurate. If tlt was on a real stock exchange there would b no way he would be allowed in any public company. We all know you don't have the ability to b objective as you are either Roger or he is your idle.
Comment by ScienceFirst on Jul 18, 2022 1:16pm
Poor little dickhead FGPstock!  Still rehasing negative propagenda.  We see into your agenda. You sound so much like our libertarian Bungee that was sued by TLT and that always had something negative to say about Roger. All CEOs have put their signatures at the bottom of official documents.  And none of them with a gun on their head.  So their signatures are officials and ...more  
Comment by vladpanka on Jul 18, 2022 4:27pm
This post has been removed in accordance with Community Policy
Comment by 99942Apophis on Jul 14, 2022 3:49pm
Rumpl3StiltSkin wrote  I'm certain that TLT wants to avoid another disastrous pp down at these levels, IF they can. Indeed, SP seems to have some of that already priced in. They did say at this recent AGM that they would need $$$ within 6th months. Based on not getting the SP up higher, raising their profile, jetting a jv or buyout, etc. This is probably the last bet I'll be ...more  
Comment by fredgoodwinson on Jul 14, 2022 6:36pm
Good last 3 posts. We are a sitting duck untril the next set of Clinical results.
Comment by Rumpl3StiltSkin on Jul 14, 2022 12:48pm
Laser, whe we meet in Vegas. After this adventure is over, you'll have to bring along some of your stash, I'd like to sample some... ;-)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250